ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Outcome"

  • 2019 American Transplant Congress

    The Combination of 3-Month Estimated Glomerular Filtration Rate and Proteinuria is a Valuable Tool for Evaluating Long-Term Kidney Graft Survival

    C. Mottola1, N. Girerd2, K. Duarte3, A. Aarnink4, M. Kessler5, L. Frimat6, S. Girerd6

    1Nephrology and Kidney Transplant Unit, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France, 2Clinical Investigation Center 1433, INSERM U1116, INI-CRCT, F-CRIN, Lorraine University, Vandoeuvre-lès-Nancy, France, 3Clinical Investigation Center 1433, INSERM 1116, INI-CRCT, F-CRIN, Lorraine Univeristy, Vandoeuvre-lès-Nancy, France, 4Laboratoire d’Histocompatibilité, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France, 5Nephrology and kidney transplant unit, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France, 6Nephrology and kidney transplant unit, INI-CRCT, F-CRIN, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France

    *Purpose: Estimated glomerular filtration rate (eGFR) measured at 1 year is the usual outcome used to predict the long-term graft survival in the field of…
  • 2019 American Transplant Congress

    Transfer of Healthy Mitochondria in Established Ischemic Injury Reduces Progression to Interstitial Fibrosis and Tubular Atrophy

    A. Bajwa1, V. Bontha1, D. Maluf1, J. Eason2, V. Mas3

    1UTHSC, Memphis, TN, 2Director of Transplant Institute, Memphis, TN, 3Director of Transplant Research Institute, Memphis, TN

    *Purpose: Ischemia induces altered bioenergetics with increased mitochondrial swelling and reactive oxygen species (ROS) and ultimately degradation of cellular function. Therapeutic interventions that target to…
  • 2019 American Transplant Congress

    Induction Type Does Not Influence Kidney Graft or Patient Survival in Recipients with a Previous Heart Transplant in the United States

    S. M. Riad1, A. Tamas1, S. Jackson2, C. Martin1

    1Medicine, University of Minnesota, Minneapolis, MN, 2Complex Care Analytics, Fairview Health Services, Minneapolis, MN

    *Purpose: Induction regimens for kidney transplant (KT) in heart recipients vary widely among transplant centers. We sought to examine the impact of kidney induction type…
  • 2019 American Transplant Congress

    Analyzing The Effect Of Liver Transplantation On Myocardial Strain Using Speckle Tracking Echocardiography In Nonalcoholic Steatohepatitis (NASH) Patients

    A. Chhatriwala, M. Lam, E. Kim, S. Raissi, N. Mazumder, J. Thomas, H. Maddur, M. Rinella

    Northwestern Memorial Hospital, Chicago, IL

    *Purpose: Nonalcoholic Steatohepatitis (NASH) is currently the second most common indication for liver transplant in the United States and is projected to increase in the…
  • 2019 American Transplant Congress

    Assessment of Health-Related Quality of Life and Graft Failure among Kidney Transplant Patients in the Benefit and Benefit-EXT Trials

    I. Purnajo1, J. L. Beaumont1, M. Polinsky2, E. Alemao2, M. J. Everly1

    1Terasaki Research Institute, Los Angeles, CA, 2Bristol Myers Squibb, Princeton, NJ

    *Purpose: To achieve patient focused drug development in renal transplant, we need to better understand how the patient’s perspective of health-related quality of life (HRQoL)…
  • 2019 American Transplant Congress

    Impact Of Aggressive Utilization Of Liver Allografts On Outcomes

    A. Rana, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss

    Baylor College of Medicine, Houston, TX

    *Purpose: Many risk factors impact outcomes for liver transplantation, among them are factors that are particular to individual transplant centers or center-level factors. Our aim…
  • 2019 American Transplant Congress

    Performance Improvement Initiative: Ambulatory Tool to Improve Tacrolimus Intrapatient Variability (IPV) Monitoring in Kidney & Liver Transplant Recipients

    T. E. Kaiser1, N. S. Ejaz1, S. Tremblay1, N. J. Parrish2, S. Schinasi2, J. Harris2, A. Govil1, N. Anwar1, R. R. Alloway1

    1University of Cincinnati, Cincinnati, OH, 2UC Health, Cincinnati, OH

    *Purpose: High tacrolimus (TAC) intrapatient variability (IPV) is associated with poorer outcomes. Manual monitoring of TAC IPV is labor intensive and not always feasible. As…
  • 2019 American Transplant Congress

    Renal Function between Tenofovir and Entecavir in Post-Liver Transplanted Hepatitis B Patients

    S. Kim, J. Kim, S. Lee, J. Rhu, Y. Chung, S. Kim, J. Joh, S. Lee, G. Choi, J. Park, S. Lee, K. Lee

    Transplantation, Samsung Medical Center, Seoul, Korea, Republic of

    *Purpose: Tenofovir, Nucleotide analogue polymerase inhibitor is already accepted as effective and tolerable drug for treatment of hepatitis B virus (HBV) as much as entecavir.…
  • 2019 American Transplant Congress

    Complete Robotic-Assisted Kidney Transplantation: Our Initial Experience

    A. Khan, C. Bhati, T. Reichman, A. Cotterell, D. Kumar, G. Gupta, L. Kamal, A. King, A. Sharma, M. Levy

    VCU Medical Center, Richmond, VA

    *Purpose: Kidney transplantation is the standard treatment for patients with ESRD. Very limited advancement has been made in its surgical aspects. Minimal invasive approach for…
  • 2019 American Transplant Congress

    Center Variability in Organ Offer Acceptance and Waitlist Mortality in Lung Transplantation

    A. Y. Choi1, M. S. Mulvihill2, J. Weber3, H. Lee3, M. Cox2, B. Yerokun2, M. Kuchibhatla3, J. A. Klapper2, M. G. Hartwig2

    1Duke University School of Medicine, Durham, NC, 2Department of Surgery, Duke University Medical Center, Durham, NC, 3Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC

    *Purpose: Lung transplantation (LTx) offers a survival benefit for patients with end-stage lung disease. When suitable donors are identified, centers must accept or decline the…
  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 155
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences